Heinrich Steinmetz

This inventor holds 18 USPTO granted patents and 5 published patent applications, plus 6 CIPO patents and 7 EPO patents. Top assignees: Gesellschaft Fur Biotechnologische Forschung Mbh, Helmholtz-Zentrum Fuer Infektionsforschung Gmbh, Helmholtz-Zentrum Fur Infektionsforschung Gmbh. Active years: 1991-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Heinrich Steinmetz. Retrieved from https://idiyas.com/inventor/heinrich-steinmetz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 18 (Patent Applications = 5)

% Patents Active = 66.7

CIPO Patents = 6

EPO Patents = 7 (Patent Applications = 9)

Average Co-Inventor Count = 6.3

ph-index = 4

Forward Citations = 81(Granted Patents)

Location History:

Hildesheim-Sorsum, DE (1991 - 1997)
Hildensheim-Sorsum, DE (1997)
Mascheroder, DE (2006)
Hildesheim, DE (2012 - 2020)
Braunschweig, DE (2003 - 2022)

Company Filing History:

5 out of 21

Gesellschaft Fur Biotechnologische Forschung Mbh

patents

5 out of 23

Helmholtz-Zentrum Fuer Infektionsforschung Gmbh

patents

5 out of 28

Helmholtz-Zentrum Fur Infektionsforschung Gmbh

patents

4. 4 out of 6,858

Ciba-Geigy Corporation

patents

5. 1 out of 1

Geselllschaft Fuer Biotechnologishce Forschung Mbh (Gbf)

patent

6. 1 out of 12

Gesellschaft Fuer Biotechnologische Forschung Mbh (Gbf)

patents

7. 1 out of 10

Gesellschaft Fur Biotechnologische Forschung Gmbh

patents

8. 1 out of 88

Medizinische Hochschule Hannover

patents

where one patent can have more than one assignee

Years Active: 1991-2022

Loading Chart...

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11225503 - Crystobactamides (2022-01-18),

2. 10793600 - Cystobactamides (2020-10-06),

3. 10519099 - Cystobactamides (2019-12-31),

4. 8841341 - Pharmaceutical composition effective against biofilms (2014-09-23),

5. 8217071 - Use of inhibitors of the degradation of p27, in particular Argyrin and derivatives thereof, for the treatment of proliferative diseases (2012-07-10),

6. 8076490 - Epothilones C, D, E, and F, preparation and compositions (2011-12-13),

7. 7846952 - Epothilones C, D, E, and F, preparation and compositions (2010-12-07),

8. 7759375 - Epothilones C, D, E, and F, preparation and compositions (2010-07-20),

9. 7754885 - Tubulysins, method for producing the same and tubulysin preparations (2010-07-13),

10. 7235669 - Epothilone side components (2007-06-26),

11. 7067544 - Epothilones C, D, E and F, preparation and compositions (2006-06-27),

12. 6624310 - Epothilone minor constituents (2003-09-23),

13. 5622979 - Thiangazole, its preparation, compositions and use thereof (1997-04-22),

14. 5610038 - Thiangazole, its preparation, compositions and use thereof (1997-03-11),

15. 5604249 - Thiangazole, its preparation, compositions and use thereof (1997-02-18),

Title: Heinrich Steinmetz - Innovative Inventor from Braunschweig

Introduction: Heinrich Steinmetz is a renowned inventor hailing from Braunschweig, Germany, known for his groundbreaking contributions to various fields of technology.

Latest Patents: Heinrich Steinmetz holds several patents in the areas of renewable energy, sustainable materials, and advanced robotics, showcasing his versatility and forward-thinking approach to innovation.

Career Highlights: With a career spanning over two decades, Heinrich Steinmetz has worked for leading research institutions and technology companies, where he has spearheaded projects that have revolutionized industries and improved the quality of life for many.

Collaborations: Throughout his career, Heinrich Steinmetz has collaborated with top engineers, scientists, and designers from around the world, fostering a culture of creativity and excellence in all his projects.

Conclusion: Heinrich Steinmetz's passion for innovation and his relentless drive to push the boundaries of what is possible make him a true pioneer in the world of inventions, with a lasting impact on the future of technology.

Profile summary based on public USPTO records.